AI-powered scope developer says new FDA clearance opens the door for telehematology

As clinical labs face a slew of workflow challenges—including personnel shortages and increasing pressure to reduce costs—automation is making a strong case for adoption. This technology’s affinity for completing otherwise tedious, repetitive tasks means that lab technologists and clinicians can spend more time making critical and better-informed decisions, some of which may lead to life-changing and life-saving results for patients.

The alliance between Siemens Healthineers and Scopio Labs will revolutionize the way laboratorians view patient samples—from under a microscope to digitized slides. Scopio Labs has granted to Siemens Healthineers global rights to distribute the Scopio X100 and Scopio X100HT, digital solutions that offer full-field imaging and an AI-powered Decision Support System with remote viewing capabilities. Scopio Labs' groundbreaking technology complements Siemens Healthineers' existing hematology portfolio to provide more expansive end-to-end workflow solutions.

Study at Tel Aviv Sourasky Medical Center is first to quantify tele-hematology's impact on laboratory performance; demonstrates more efficient workflows and decrease in costs.